Latest News and Press Releases
Want to stay updated on the latest news?
-
HOPEWELL, N.J., July 13, 2021 (GLOBE NEWSWIRE) -- Gennao Bio, a privately held genetic medicines company developing first-in-class, targeted nucleic acid therapeutics, today announced the...
-
London, United Kingdom, July 13, 2021 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology provider Inspirata announced today that King’s Health Partners ECMC and Guy’s and St Thomas’ NHS...
-
SEATTLE, July 07, 2021 (GLOBE NEWSWIRE) -- OncoResponse, a biotechnology company harnessing the power of the human immune system to identify and develop novel monoclonal antibodies to...
-
London, United Kingdom, July 07, 2021 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology provider Inspirata announced today that its UK subsidiary, Inspirata Europe, has achieved...
-
MENLO PARK, CA, NEW YORK, NY, and WASHINGTON, DC, July 06, 2021 (GLOBE NEWSWIRE) -- The U.S Department of Education’s Institute of Education Sciences has awarded $10 million to SRI Education and the...
-
TORONTO, July 06, 2021 (GLOBE NEWSWIRE) -- Psirenity Chairman Chris McCullough today announced the appointment of Mark Thompson to Chief Executive Officer and Wayne Kreppner to Chief Operating...
-
EDMONTON, Alberta, July 06, 2021 (GLOBE NEWSWIRE) -- Translational Research in Oncology (TRIO), a global academic clinical research organization, announced today enrolment completion in coopERA...
-
London, UK – 5 July 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health,...
-
MIAMI, July 02, 2021 (GLOBE NEWSWIRE) -- Mycotopia Therapies, Inc., (OTC Pink: TPIA) (the “Company”) announced today an upcoming complimentary Psychedelic Industry summit will take place virtually...
-
FLORHAM PARK, N.J., July 01, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies based on the Company’s...